$0.01
3.03% yesterday
Nasdaq, Nov 20, 09:51 pm CET
ISIN
US30048L1044
Symbol
EVFM

Evofem Biosciences, Inc. Stock price

$0.01
-0.00 3.03% 1M
+0.00 6.67% 6M
-0.00 3.03% YTD
-0.00 4.00% 1Y
-9.74 99.90% 3Y
-4,368.74 100.00% 5Y
-98,437.49 100.00% 10Y
-134,999.99 100.00% 20Y
Nasdaq, Closing price Thu, Nov 20 2025
-0.00 3.03%
ISIN
US30048L1044
Symbol
EVFM
Industry

Key metrics

Basic
Market capitalization
$1.3m
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
negative | -
P/S
0.1 | -
EV/Sales
- | -
EV/FCF
-
P/B
-
Financial Health
Equity Ratio
-279.4%
Return on Equity
13.5%
ROCE
-
ROIC
-
Debt/Equity
-
Financials (TTM | estimate)
Revenue
$17.3m | -
EBITDA
$-3.6m | -
EBIT
$-4.5m | -
Net Income
$-6.3m | -
Free Cash Flow
$-5.2m
Growth (TTM | estimate)
Revenue
-2.5% | -
EBITDA
67.9% | -
EBIT
59.6% | -
Net Income
-110.9% | -
Free Cash Flow
-46.5%
Margin (TTM | estimate)
Gross
79.7%
EBITDA
-20.6% | -
EBIT
-26.1%
Net
-36.2% | -
Free Cash Flow
-30.3%
More
EPS
$-0.1
FCF per Share
-
Short interest
11.0%
Employees
32
Rev per Employee
$610.0k
Show more

Is Evofem Biosciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,048 stocks worldwide.

Evofem Biosciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Evofem Biosciences, Inc. forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a Evofem Biosciences, Inc. forecast:

Hold
50%
Sell
50%

Financial data from Evofem Biosciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
17 17
2% 2%
100%
- Direct Costs 3.50 3.50
19% 19%
20%
14 14
3% 3%
80%
- Selling and Administrative Expenses 21 21
6% 6%
119%
- Research and Development Expense 1.73 1.73
40% 40%
10%
-3.56 -3.56
68% 68%
-21%
- Depreciation and Amortization 0.95 0.95
1,088% 1,088%
6%
EBIT (Operating Income) EBIT -4.51 -4.51
60% 60%
-26%
Net Profit -6.25 -6.25
111% 111%
-36%

In millions USD.

Don't miss a Thing! We will send you all news about Evofem Biosciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Evofem Biosciences, Inc. Stock News

Neutral
PRNewsWire
7 days ago
-- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter -- -- Delivered $1.0 Million of Operating Income in Q3 2025 -- SAN DIEGO , Nov. 13, 2025 /PRNewswire/ -- Women's health innovator Evofem Biosciences, Inc. (Evofem or the Company) (OTCID: EVFM), today announced financial results for the three- and nine-month periods ended September 30, 2025 and provided a bus...
Neutral
PRNewsWire
about one month ago
-- Evofem Shareholders Did Not Approve the Merger with Aditxt -- -- Evofem Pivots to Target National Listing for Stock, Growth Capital to Catalyze Net Sales -- SAN DIEGO , Oct. 20, 2025 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCID: EVFM) ("Evofem" or the "Company"), today announced that at a Special Meeting of Stockholders held this morning, its stockholders did not approve the proposal to a...
Neutral
PRNewsWire
about 2 months ago
— First ex-U.S. Regulatory Filing for SOLSOEC® — — Pharma 1 Targets 1H 2026 Launch in UAE for  SOLOSEC® to Treat Bacterial Vaginosis and Trichomoniasis,  leveraging its commercial infrastructure and expertise in women's health — SAN DIEGO , Oct. 1, 2025 /PRNewswire/ -- Women's health innovator Evofem Biosciences, Inc. (Evofem, or the Company) (OTCID: EVFM) announced today that its licensee for ...
More Evofem Biosciences, Inc. News

Company Profile

Evofem Biosciences, Inc. develops therapeutic solutions to meet sexual and reproductive health needs of women. Its product include Amphora Contraceptive for the prevention of pregnancy, antimicrobial drug product for the prevention of sexually transmitted infections and Antimicrobial Drug product to prevent the reoccurrence of bacterial vaginosis. The company was founded in 2007 and is headquartered in San Diego, CA.

Head office United States
CEO Saundra Pelletier
Employees 32
Founded 2007
Website www.evofem.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today